US 11439683
Anti-angiogenic therapy of metastatic colorectal cancer
granted A61KA61K38/179A61K45/06
Quick answer
US patent 11439683 (Anti-angiogenic therapy of metastatic colorectal cancer) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/179, A61K45/06, A61P, A61P35/00